Inflammasome-Driven Interleukin-1α and Interleukin-1β Production in Atherosclerotic Plaques Relates to Hyperlipidemia and Plaque Complexity

Xintong Jiang, Feilong Wang, Yajuan Wang, Anton Gisterå, Joy Roy, Gabrielle Paulsson-Berne, Ulf Hedin, Amir Lerman, Göran K. Hansson, Joerg Herrmann, Zhong qun Yan

Research output: Contribution to journalArticle

Abstract

CANTOS (Canakinumab Antiinflammatory Thrombosis Outcome Study) confirmed interleukin (IL)–1β as an appealing therapeutic target for human atherosclerosis and related complications. However, there are serious gaps in our understanding of IL-1 production in atherosclerosis. Herein the authors show that complex plaques, or plaques derived from patients with suboptimally controlled hyperlipidemia, or on no or low-intensity statin therapy, demonstrated higher recruitable IL-1β production. Generation of mature IL-1β was matched by IL-1α release, and both were attenuated by inhibition of NLR family pyrin domain containing 3 or caspase. These findings support the inflammasome as the main pathway for IL-1α/β generation in atherosclerosis and high-intensity lipid-lowering therapies as primary and additional anti-IL-1-directed therapies as secondary interventions in high-risk patients.

Original languageEnglish (US)
Pages (from-to)304-317
Number of pages14
JournalJACC: Basic to Translational Science
Volume4
Issue number3
DOIs
StatePublished - Jun 1 2019

Fingerprint

Inflammasomes
Atherosclerotic Plaques
Hyperlipidemias
Interleukin-1
Atherosclerosis
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Therapeutics
Caspase 3
Thrombosis
Anti-Inflammatory Agents
Outcome Assessment (Health Care)
Lipids

Keywords

  • atherosclerosis
  • hypercholesterolemia
  • inflammasome
  • inflammation
  • interleukin-1

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Inflammasome-Driven Interleukin-1α and Interleukin-1β Production in Atherosclerotic Plaques Relates to Hyperlipidemia and Plaque Complexity. / Jiang, Xintong; Wang, Feilong; Wang, Yajuan; Gisterå, Anton; Roy, Joy; Paulsson-Berne, Gabrielle; Hedin, Ulf; Lerman, Amir; Hansson, Göran K.; Herrmann, Joerg; Yan, Zhong qun.

In: JACC: Basic to Translational Science, Vol. 4, No. 3, 01.06.2019, p. 304-317.

Research output: Contribution to journalArticle

Jiang, Xintong ; Wang, Feilong ; Wang, Yajuan ; Gisterå, Anton ; Roy, Joy ; Paulsson-Berne, Gabrielle ; Hedin, Ulf ; Lerman, Amir ; Hansson, Göran K. ; Herrmann, Joerg ; Yan, Zhong qun. / Inflammasome-Driven Interleukin-1α and Interleukin-1β Production in Atherosclerotic Plaques Relates to Hyperlipidemia and Plaque Complexity. In: JACC: Basic to Translational Science. 2019 ; Vol. 4, No. 3. pp. 304-317.
@article{5cc06d753646432abc5b7fcb881e3e0e,
title = "Inflammasome-Driven Interleukin-1α and Interleukin-1β Production in Atherosclerotic Plaques Relates to Hyperlipidemia and Plaque Complexity",
abstract = "CANTOS (Canakinumab Antiinflammatory Thrombosis Outcome Study) confirmed interleukin (IL)–1β as an appealing therapeutic target for human atherosclerosis and related complications. However, there are serious gaps in our understanding of IL-1 production in atherosclerosis. Herein the authors show that complex plaques, or plaques derived from patients with suboptimally controlled hyperlipidemia, or on no or low-intensity statin therapy, demonstrated higher recruitable IL-1β production. Generation of mature IL-1β was matched by IL-1α release, and both were attenuated by inhibition of NLR family pyrin domain containing 3 or caspase. These findings support the inflammasome as the main pathway for IL-1α/β generation in atherosclerosis and high-intensity lipid-lowering therapies as primary and additional anti-IL-1-directed therapies as secondary interventions in high-risk patients.",
keywords = "atherosclerosis, hypercholesterolemia, inflammasome, inflammation, interleukin-1",
author = "Xintong Jiang and Feilong Wang and Yajuan Wang and Anton Gister{\aa} and Joy Roy and Gabrielle Paulsson-Berne and Ulf Hedin and Amir Lerman and Hansson, {G{\"o}ran K.} and Joerg Herrmann and Yan, {Zhong qun}",
year = "2019",
month = "6",
day = "1",
doi = "10.1016/j.jacbts.2019.02.007",
language = "English (US)",
volume = "4",
pages = "304--317",
journal = "JACC: Basic to Translational Science",
issn = "2452-302X",
publisher = "Elsevier Inc.",
number = "3",

}

TY - JOUR

T1 - Inflammasome-Driven Interleukin-1α and Interleukin-1β Production in Atherosclerotic Plaques Relates to Hyperlipidemia and Plaque Complexity

AU - Jiang, Xintong

AU - Wang, Feilong

AU - Wang, Yajuan

AU - Gisterå, Anton

AU - Roy, Joy

AU - Paulsson-Berne, Gabrielle

AU - Hedin, Ulf

AU - Lerman, Amir

AU - Hansson, Göran K.

AU - Herrmann, Joerg

AU - Yan, Zhong qun

PY - 2019/6/1

Y1 - 2019/6/1

N2 - CANTOS (Canakinumab Antiinflammatory Thrombosis Outcome Study) confirmed interleukin (IL)–1β as an appealing therapeutic target for human atherosclerosis and related complications. However, there are serious gaps in our understanding of IL-1 production in atherosclerosis. Herein the authors show that complex plaques, or plaques derived from patients with suboptimally controlled hyperlipidemia, or on no or low-intensity statin therapy, demonstrated higher recruitable IL-1β production. Generation of mature IL-1β was matched by IL-1α release, and both were attenuated by inhibition of NLR family pyrin domain containing 3 or caspase. These findings support the inflammasome as the main pathway for IL-1α/β generation in atherosclerosis and high-intensity lipid-lowering therapies as primary and additional anti-IL-1-directed therapies as secondary interventions in high-risk patients.

AB - CANTOS (Canakinumab Antiinflammatory Thrombosis Outcome Study) confirmed interleukin (IL)–1β as an appealing therapeutic target for human atherosclerosis and related complications. However, there are serious gaps in our understanding of IL-1 production in atherosclerosis. Herein the authors show that complex plaques, or plaques derived from patients with suboptimally controlled hyperlipidemia, or on no or low-intensity statin therapy, demonstrated higher recruitable IL-1β production. Generation of mature IL-1β was matched by IL-1α release, and both were attenuated by inhibition of NLR family pyrin domain containing 3 or caspase. These findings support the inflammasome as the main pathway for IL-1α/β generation in atherosclerosis and high-intensity lipid-lowering therapies as primary and additional anti-IL-1-directed therapies as secondary interventions in high-risk patients.

KW - atherosclerosis

KW - hypercholesterolemia

KW - inflammasome

KW - inflammation

KW - interleukin-1

UR - http://www.scopus.com/inward/record.url?scp=85067238688&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85067238688&partnerID=8YFLogxK

U2 - 10.1016/j.jacbts.2019.02.007

DO - 10.1016/j.jacbts.2019.02.007

M3 - Article

AN - SCOPUS:85067238688

VL - 4

SP - 304

EP - 317

JO - JACC: Basic to Translational Science

JF - JACC: Basic to Translational Science

SN - 2452-302X

IS - 3

ER -